Artificially intelligent nanoarrays for disease detection via volatolomics

Delayed diagnosis of many diseases is caused by technology limitations of currently available methods. Therefore, there is a need for novel technology that would allow efficient early detection, population stratification for personalized therapy, and for rapid assessment of treatment efficacy. Such an emerging approach is based on artificially intelligent sensing arrays of solid-state or flexible sensors that detect the so-called "volatolomics", viz. profiles of volatile organic compounds (VOCs) which are by-products of metabolic processes and emit from various body fluids.